Related Experiment Videos
Combined light and electron-microscope morphometric studies of acute puromycin aminonucleoside nephropathy in rats
Abstract:
Morphometric observations were made on rats injected subcutaneously daily with puromycin aminonucleoside after two, four, six and eight daily injections. As a result it was possible to correlate the morphological alterations of the various glomerular components with the biochemical manifestations of the nephrotic syndrome particularly the onset of proteinuria. There was already significant loss of foot processes of the glomerular epithelial cells by the 2nd day, that is before the onset of proteinuria, suggesting that the loss of foot processes is a consequence of some metabolic impairment produced by the puromycin aminonucleoside which also subsequently causes the proteinuria. Swelling of the glomerular epithelial cells became significant by the 6th and 8th day of injection after the development of proteinuria, suggesting that it is a consequence of the increased amount of protein in the glomerular filtrate. Two independent morphometric methods suggest a decrease in the amount of glomerular basement membrane. Unfortunately because of difficulties in the determination of mean glomerular volumes it is not possible to be absolutely certain that this is a true finding, however it is what would be expected if the synthesis of basement membrane was depressed by the puromycin aminonucleoside.
Insights
Puromycin aminonucleoside causes early foot process loss in rat kidneys before proteinuria develops. This suggests a metabolic defect, not direct filtration injury, initiates nephrotic syndrome.
Area of Science:
- Nephrology
- Pathology
- Toxicology
Background:
- The nephrotic syndrome is characterized by proteinuria, edema, and hypoalbuminemia.
- Puromycin aminonucleoside (PAN) is a nephrotoxic agent used to induce experimental nephrotic syndrome in rats.
Purpose of the Study:
- To investigate the temporal relationship between morphological changes in rat glomeruli and the onset of proteinuria induced by PAN.
- To elucidate the primary site of injury and the sequence of events leading to PAN-induced nephrotic syndrome.
Main Methods:
- Rats were injected subcutaneously with PAN daily.
- Morphometric analysis of glomerular components was performed at 2, 4, 6, and 8 days post-injection.
- Correlation of morphological alterations with biochemical markers, specifically proteinuria.
Main Results:
- Significant loss of glomerular epithelial cell foot processes was observed by day 2, preceding proteinuria.
- Glomerular epithelial cell swelling became significant by days 6 and 8, coinciding with established proteinuria.
- Morphometric methods indicated a potential decrease in glomerular basement membrane, possibly due to reduced synthesis.
Conclusions:
- Foot process effacement is an early event in PAN nephropathy, suggesting a primary metabolic insult by PAN.
- Proteinuria appears secondary to foot process damage and subsequent filtration barrier dysfunction.
- PAN may inhibit glomerular basement membrane synthesis, contributing to glomerular damage.